空气传播
发表于 2025-3-25 05:21:34
Infliximab: From the Idea to the Productle and membrane- bound TNF-α . Infliximab does not bind to TNF-β (lymphotoxin α ), a related cytokine that utilizes the same receptors as TNF-α. Thus infliximab was developed as a therapeutic agent for various inflammatory chronic diseases that are believed to be driven by the pro-inflammatory cytokine TNF-α.
ectropion
发表于 2025-3-25 08:55:07
http://reply.papertrans.cn/19/1876/187535/187535_22.png
BOLT
发表于 2025-3-25 14:46:42
Biologics in Cutaneous Lymphomatracutaneous disease at the time of diagnosis. They can be distinguished into cutaneous T-cell lymphomas (CTCL), cutaneous B-cell lymphomas (CBCL) and the rare precursor dendritic cell neoplasms. The PCL are now classified in the new WHO-EORTC classification (.; Table 14.1).
–LOUS
发表于 2025-3-25 15:51:15
http://reply.papertrans.cn/19/1876/187535/187535_24.png
遗留之物
发表于 2025-3-25 23:27:31
http://reply.papertrans.cn/19/1876/187535/187535_25.png
多山
发表于 2025-3-26 01:01:56
http://reply.papertrans.cn/19/1876/187535/187535_26.png
alleviate
发表于 2025-3-26 05:30:39
Claire R. McInerney,Michael E. D. Koenigtem. Examples include antibodies directed against very specific molecular components of the immune response, for example, pro-inflammatory cytokines, or naturally occurring cytokine inhibitors such as IL-1 receptor antagonist (IL-1ra).
用树皮
发表于 2025-3-26 11:09:56
http://reply.papertrans.cn/19/1876/187535/187535_28.png
小说
发表于 2025-3-26 14:23:41
https://doi.org/10.1007/978-3-319-03698-4n overreactive immune system. Carrier substances that falsely inform the body about an ongoing infection are produced in large quantities. The immune system answers by starting a strong immune response. The body’s own tissues are attacked and continuously destroyed. Specific models of reaction have
玩忽职守
发表于 2025-3-26 18:52:20
Springer Texts in Business and Economicsle and membrane- bound TNF-α . Infliximab does not bind to TNF-β (lymphotoxin α ), a related cytokine that utilizes the same receptors as TNF-α. Thus infliximab was developed as a therapeutic agent for various inflammatory chronic diseases that are believed to be driven by the pro-inflammatory cytok